SBI Securities’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278 Buy
246
+12
+5% +$14 ﹤0.01% 3222
2026
Q1
$274 Buy
234
+10
+4% +$13 ﹤0.01% 3105
2025
Q4
$343 Sell
224
-10
-4% -$17 ﹤0.01% 3016
2025
Q3
$400 Sell
234
-47
-17% -$149 ﹤0.01% 3063
2025
Q2
$922 Buy
281
+19
+7% +$71 ﹤0.01% 2714
2025
Q1
$731 Buy
262
+110
+72% +$720 ﹤0.01% 2721
2024
Q4
$2.64K Buy
+152
New +$2.6K ﹤0.01% 2189

Other funds holding BNGO

SBI Securities's BNGO Position: Q2 2026 in Review

SBI Securities increased its Bionano Genomics (BNGO) stake by 5.1% in Q2 2026, buying an estimated $14 and bringing the position to 246 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

SBI Securities first reported a position in BNGO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.64K in Q4 2024. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • SBI Securities held 246 shares of Bionano Genomics worth $278 as of Q2 2026.
  • SBI Securities bought 12 Bionano Genomics shares in Q2 2026, an estimated $14.
  • Bionano Genomics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3222 holding.
  • SBI Securities first reported a position in Bionano Genomics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bionano Genomics position peaked at $2.64K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.